Intuitive Surgical Inc ISRG

Business model holds this up; Valuation is the soft spot.

The price needs 18.0% growth a year for ten years. The AI thinks 13.0% is achievable, at a 30.0% margin.

At the corrected 18% required growth for 30% margins, the -5% gap shows ISRG is overvalued as 13% achievable growth falls short, weakening the investment case with no margin of safety.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Write why this business works, set your own fair value, and let the briefing speak only when a rule you wrote is crossed.